Endogenous opioid systems and alcohol addiction

Psychopharmacology

Volumn 129, Issue 2, 1997, Pages 99-111

  Herz, A ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

alcohol addiction; alcohol reinforcement; alcohol self administration; endogenous opioid peptides; genetic models; mesolimbic dopamine reward system; naloxone; naltrexone; opioid addiction; opioid antagonists; opioid receptors; prevention of relapse

Indexed keywords

ALCOHOL; BETA ENDORPHIN; BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DOPAMINE; DYNORPHIN; ENDORPHIN; ENKEPHALIN; ICI 174648; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALMEFENE; NALOXONE; NALTREXONE; NALTRIBENE; NALTRINDOLE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE PEPTIDE; OPIATE RECEPTOR; RECEPTOR SUBTYPE; TETRAHYDROISOQUINOLINE; UNCLASSIFIED DRUG;

ADDICTION; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL MODEL; BEHAVIOR; DYSPHORIA; GENETIC MODEL; HUMAN; MESOLIMBIC DOPAMINERGIC SYSTEM; NERVOUS SYSTEM; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE ADDICTION; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; REWARD; VENTRAL TEGMENTUM;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; ETHANOL; HUMANS; MESENCEPHALON; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RECEPTORS, OPIOID;

EID: 0031037561     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050169     Document Type: Review

References (138)

1. Acquas E, Carboni E, Leone P, Di Chiara G (1989) SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology 99:151-155
2. Acquas E, Meloni M, Di Chiara G (1993) Blockade of δ-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur J Pharmacol 230:239-241
3. Altshuler HL, Phillips PE, Feinhandler DA (1980) Alteration of ethanol self-administration by naltrexone. Life Sci 26:679-688
4. Amalric M, Cline EJ, Martinez JL, Bloom FE, Koob GF (1987) Rewarding properties of β-endorphin as measured by conditioned place preference. Psychopharmacology 91:14-19
5. Bals-Kubik R, Shippenberg TS, Herz A (1990) Involvement of central μ and δ opioid receptors in mediating the reinforcing effects of β-endorphin in the rat. Eur J Pharmacol 175:63-69
6. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS (1993) Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264:489-495
7. Belluzzi DJ, Stein L (1977) Enkephalin may mediate euphoria and drive-reduction reward. Nature 266:556-558
8. Benjamin D, Grant ER, Pohorecky LA (1993) Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res 621:137-140
9. Bohn MJ, Kranzler HR, Beazoglou D, Staehler BA (1994) Naltrexone and brief counseling to reduce heavy drinking. Am J Addict 3:91-99
10. Bozarth MA, Wise RA (1986) Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement. In: Harris LS (ed) Problems of drug dependence. NIDA Research Monograph 67. NIDA, Washington, D.C., pp 190-196
11. Brown DR, Holtzman SG (1979) Suppression of deprivation-induced food and water intake in rats and mice by naloxone. Pharmacol Biochem Behav 11:567-573
12. Carr GD, Fibiger HC, Phillips AG (1989) Conditioned place preference as a measure of drug reward. In: Liebman JM. Cooper SJ (eds) The neuropharmacological basis of reward. Oxford Scientific Publications. Oxford, pp 264-319
13. Charness ME, Hu G, Edwards RH, Querimit LA (1993) Ethanol increases δ-opioid receptor gene expression in neuronal cell lines. Mol Pharmocol 44:1119-1127
14. Cohen G, Collins M (1970) Alkaloids from catecholamines in adrenal tissue: possible role of alcoholism. Science 167:1749-1751
15. Corbett AD, Paterson SL, Kosterlitz HW (1993) Selectivity of ligands for opioid receptors. In: Herz A (ed) Handbook of experimental pharmacolology: vol opioids I. Springer, Heidelberg, pp 645-679
16. Crowley TJ, Wagner JE, Zerbe G, Macdonald M (1985) Naltroxene-induced dysphoria in former opioid addicts. Am J Psychiatry 142:1081-1084
17. Davis EA, Walsh M (1970) Alcohol, amines, and alkaloids: possible biochemical basis of alcohol addiction. Science 167:1005-1006
18. De Haven-Hudkins DL, Brostrom FA. Allen JT, Lesko LJ, Ferkany JW, Kaplita PV, Mavunkel BJ, Rzeszotarski WJ. Steranka LR (1990) Pharmacologic profile of NPC 168 (naltrexonephenyl oxime), a novel compound with activity at opioid receplors. Pharmacol Biochem Behav 37:497-504
19. De Waele J-P, Papachristou DN, Gianoulakis C (1992) The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic β-endorphin system to ethanol than the alcohol-avoiding BDA/2 mice. J Pharmacol Exp Ther 261: 788-794
20. De Waele JP, Kiianmaa K, Gianoulakis C (1994) Spontaneous and ethanol-stimulated in vitro release of β-endorphin by the hypothalamus of AA and ANA rats. Alcohol Clin Exp Res 18:1468-1473
21. De Waele J-P, Kiianmaa K, Gianoulakis C (1995) Distribution of the μ and δ opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats. J Pharmacol Exp Ther 275:518-527
22. Diana M, Pistis M, Muntoni A, Gessa G (1995) Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J Pharmacol Exp Ther 272:781-785
23. Di Chiara G, Imperato A (1988a) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080
24. Di Chiara G, Imperato A (1988b) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278
25. Dole VP, Nyswander ME (1967) Heroin addiction - a metabolic disease. Arch Int Med 120:19-24
26. Doty P, de Wit H (1995) Effects of naltrexone pretreatment on the subjective and performance effects of ethanol in social drinkers. Behav Pharmacol 6:386-394
27. Downs DA, Woods JH (1976) Naloxone as a negative reinforcer in rhesus monkeys: effects of dose, schedule, and narcotic regimen. Pharmacol Rev 27:397-405
28. Dum J, Herz A (1984) Endorphinergic modulation of neural reward systems indicated by behavioral changes. Pharmacol Biochem Behav 21:259-266
29. Dum J, Herz A (1987) Opioids and motivation. Interdise Sci Rev 12:180-190
30. Dum J, Gramsch Ch, Herz A (1983) Activation of hypothalamic β-endorphin pools by reward induced by highly palatable food. Pharmacol Biochem Behav 18:443-447
31. Eriksson K (1968) Genetic selection for voluntary alcohol consumption in the albino rat. Science 129:739-741
32. Ettenberg A, Pettit HO, Bloom FE, Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78:204-209
33. Fibiger HC, Phillips AG (1986) Reward, motivation, cognition: psychobiology of mesotelencephalic dopamine systems. In: Handbook of physiology, vol IV. American Physiological Society, Bethesda, pp 647-675
34. Froehlich JC (1995) Genetic factors in alcohol self-administration. J Clin Psychiatry 56 [Suppl 7]: 15-23
35. Froehlich JC, Harts J, Lumeng L, Li T-K (1990) Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 35:385-390
36. Froehlich JC, Zweifel M, Harts J, Lumeng L, Li T-K (1995) Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology 103:467-472
37. George FR, Goldberg SR (1989) Genetic approaches to the analysis of addiction processes. Trend Pharmacol Sci 10:78-83
38. George SR, Fan T, Ng G YK, Jung SY, O'Dowd BF, Naranjo CA (1995) Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: reversal by increasing synaptic dopamine. J Pharmacol Exp Ther 273 [Suppl 7]:373-379
39. 1 receptors in the initiation of heroin self-administration in the rat. Psychopharmacology 114:486-494
40. Gessa GL, Montoni F, Collo M, Vargiu L, Mereu G (1985) Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 348:201-203
41. Gianoulakis C (1989) The effect of ethanol on the biosynthesis and regulation of opioid peptides. Experientia 45:428-435
42. Gianoulakis C (1993) Endogenous opioids and excessive alcohol consumption. J Psychiatr Neurosci 18:148-156
43. Gianoulakis C, De Waele JP, Kiianmaa K (1992) Differences in the brain and pituitary β-endorphin system between the alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol Clin Exp Res 16:453-459
44. Glick SD, Maisonneuve IM, Raucci J, Archer S (1995) Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681:147-152
45. Goldstein A (1976) Opioid peptides (endorphins) in pituitary and brain. Science 193:1081-1086
46. Greenstein RA, Fudala PJ, O'Brien Ch (1992)Alternative pharmacotherapies for opiate addiction. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG (eds) Substance abuse. A comprehensive textbook, 2nd edn. Williams & Wilkins, Baltimore, pp 562-574
47. Grevert P, Goldstein A (1977) Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects. Proc Natl Acad Sci USA 74:1291-1294
48. Grevert P, Goldstein A (1978) Endorphins: naloxone fails to alter experimental pain or mood in humans. Science 199:1093-1095
49. Grisel JE, Grahame NJ, Mogil JS, Belknap JK, Low MJ (1995) Decreased voluntary ethanol consumption in transgenic mice lacking β-endorphin. Abstr Neurosci Congr 21:1699
50. Herz A (1993) Opioids I/II. In: Handbook of experimental pharmacology, vol 104 I/II. Springer. Heidelberg, pp 1-815, 1-840
51. Herz A, Spanagel R (1995) Endogenous opioids and addiction. In: Tseng LF (ed) The pharmacology of opioids. Harwood, Germany, pp 445-462
52. Heyser CJ, Roberts AJ, Schulteis G, Hyytiä P, Koob GF (1995) Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. Abstr Neurosci Congr 21:1698
53. Hollister LE, Johnson K, Boukhabza D, Gillespie HK (1981) Aversive effects of naltrexone in subjects not dependent on opiates. Drug Alcohol Depend 8:37-41
54. Hubbell CL, Czirr SA, Hunter GA, Beaman CM, LeCann NC, Reid LD (1986) Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol 3:39-54
55. Hubbell CL, Marglin SH, Spitalnic SJ, Abelson ML, Wild KD, Reid LD (1991) Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage. Alcohol 8:355-367
56. Hyytiå P (1993a) Alcohol reinforcement: genetic differences and attenuation by opioid antagonists. Academic dissertation, Helsinki
57. Hyytiå P (1993b) Involvement of μ-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol Biochem Behav 45:697-701
58. Hyytiå P. Sinclair JD (1993) Oral etonitazene and cocaine consumption by AA. ANA and wistar rats. Psychopharmacology 111:409-414
59. Imperato A, Di Chiara G (1986) Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239:219-228
60. Jamensky NT, Kiianmaa K, Thakur M, Gianoulakis C (1995) Content of proenkephalin and prodynorphin mRNAs in distinct brain regions of the alcohol-preferring (AA) and the alcohol-avoiding (ANA) rats. Abstr Neurosci Congr 21:1699
61. Jones RT, Herning RI (1979) Naloxone-induced mood and physiologic changes in normal volunteers. In: Usdin E, Bunney WE, Kline NS (eds) Endorphins in mental health research. Macmillan, London, pp 484-491
62. Kalant H (1985) Interactions of ethanol and neuropeptides. In: Naranjo CA, Sellers EM (eds) Research advances in new psychopharmacological treatments for alcoholism. Elsevier, Amsterdam, pp 69-85
63. Khachaturian H, Lewis ME, Tsou K, Watson St (1985) β-endorphin, α-MSH, ACTH and related peptides. In: Björklund A, Hökfelt (eds) Handbook of chemical neuroanatomy, vol 4. Elsevier, Amsterdam, pp 216-272
64. Kiianmaa K, Nurmi M, Nykänen I, Sinclair JD (1995) Effect of ethanol on extracellular dopamine in the nucleus accumbens of alcohol-preferring AA and alcohol-avoiding ANA rats. Pharmacol Biochem Behav 52: 29-34
65. Knapp RJ, Malatynska E. Collins N, Fang L, Wang JY, Hruby VJ, Roeske WR, Yamamura HI (1995) Molecular biology and pharmacology of cloned opioid receptors. FASEB J 9:516-525
66. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184
67. Koob GF, Goeders NE (1989) Neuroanatomical substrates of drug self-administration. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Oxford Science Foundation, pp 214-263
68. Koob GF, Rassnick S, Heinrichs S, Weiss F (1994) Alcohol, the reward system and dependence. In: Jansson B, Jörnvall H, Rydberg U, Terenius L, Vallee BL (eds) Toward a molecular basis of alcohol use and abuse. Birkhäuser, Basel, pp 103-114
69. Kornet M, Goosen C, Van Ree JM (1991) Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology 104:367-376
70. 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol Biochem Behav 52:153-159
71. Lê AD, Poulos CK, Quan B, Chow S (1993) The effect of selective blockade of 6 and μ opiate receptors on ethanol consumption by C 57B2/6 mice in a restricted access paradigm. Brain Res 630:330-333
72. Leone P, Di Chiara G (1987) Blockade of D-1 receptors by SCH 23390 antagonizes morphine and amphetamine-induced place preference conditioning. Eur J Pharmacol 135:251-254
73. Levine AS, Hess S, Morley JE (1983) Alcohol and the opiate receptor. Alcohol Clin Exp Res 7:83-84
74. Li TK, Lumeng L, McBride WJ, Murphy JMR (1987) Rodent lines selected for factors affecting alcohol consumption. In: Lindros KO, Ylikarí R, Kiianmaa K (eds) Advances in biomedical alcohol research. Alcohol Suppl 1:91-96
75. Lumeng L, Doolittle DP, Li TK (1986) New duplicate lines of rats differ in voluntary alcohol consumption. Alcohol 21:A 125
76. Maisonneuve IM, Archer S, Glick SD (1994) U 50,488, a K opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett 181:57-60
77. Magnan J, Paterson SJ, Tavani A, Kosterlitz HW (1982) The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmiedeberg's Arch Pharmacol 319:197-205
78. Malcolm R, O'Neil PM, Von JM, Dickerson PC (1987) Naltrexone and dysphoria: a double-blind placebo controlled trial. Biol Psychiatry 22:710-716
79. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurol Sci 11:308-314
80. Marfaing-Jallat P, Miceli D, Le Magnen J (1983) Decrease in ethanol consumption by naloxone in naive and dependent rats. Pharmacol Biochem Behav 18:537-539
81. Mason BJ, Ritro EC, Salvato F, Zimmer E, Goldberg G, Welch B (1993) Preliminary dose finding studies for nalmefene treatment of alcoholism. Alcohol Clin Exp Res 18:464
82. Meisen RA, Lemaire GA (1993) Drug self-administration. In: van Harren F (ed) Methods in behavioral pharmacology. Elsevier, Amsterdam, pp 257-300
83. Mucha RF, Iversen SD (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination. Psychopharmacology 82:241-247
84. Mucha RF, Millan MJ, Herz A (1985) Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central β-endorphin. Psychopharmacology 86:286-285
85. Mucha RF, Herz A (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86:274-280
86. Myers RD (1989) Isoquinolines, beta-carbolines and alcohol drinking: involvement of opioid and dopaminergic mechanisms. Experientia 45:436-442
87. Myers RD, Borg S, Mossberg R (1986) Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol 3:383-388
88. Nevo I, Hamon M (1995) Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int 26:305-336
89. O'Malley S, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 49:881-887
90. Parkinen EO, Williams KL, Woods JH (1995) Naltrexon effects on oral sucrose and ethanol-reinforcement: responding in rhesus monkeys. Soc Neurosci Congr 21:1698
91. Pentney RJW, Gratton A (1991) Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: an in vivo electrochemical study. Neuroscience 45:95-102
92. Pettit HO, Ettenberg A, Bloom FE. Koob GF (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administratioin. Psychopharmacology 84:167-173
93. Phillips TJ, Feller DJ, Crabbe JC (1989) Selected mouse lines, alcohol and behavior. Experientia 45:805-827
94. Przewlocki R (1993) Opioid systems and stress. In: Herz A (ed) Handbook of experimental pharmacology, vol Opioids II. Springer, Heidelberg, pp 293-315
95. Reid LD, Hunter GA (1984) Morphine and nuloxone modulate intake of ethanol. Alcohol 1:33-37
96. Reisine T, Bell GI (1993) Molecular biology of opioid receptors. Trends Neurol Sci 16:506-510
97. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive -sensitization theory of addiction. Brain Res Rev 18:247-291
98. Rossetti ZL, Melis F, Carboni S, Gessa GL (1992) Dramatic depletion of mesolimbic extracellular dopamine after withdrawal from morphine, alcohol or cocaine: a common neurochemical substrate for drug dependence. In: Kalivas P, Samson H (eds) The neurobiology of drug and alcohol addiction. Ann N Y Acad Sci 654:513-516
99. Samson HH, Doyle TF (1985) Oral ethanol self-administration in the rat: effect of naloxone. Pharmacol Biochem Behav 22:91-99
100. Samson HH, Tolliver GA, Haraguchi M, Hodge CW (1992) Alcohol self-administration: role of mesolimbic dopamine. In: Kalivas PW, Samson H (eds) The neurobiology of drug and alcohol addiction. Ann NY Acad Sci 654:242-253
101. Samson HH, Hodge CW, Tolliver GA, Haraguchi M (1993) Effect of dopamine agonists and antagonists on ethanol-reinforced behavior: the involvement of the nucleus accumbens. Brain Res Bull 30:133-141
102. Sandi C, Borrell J, Guaza C (1988) Naloxone decreases ethanol consumption within a free choice paradigm in rats. Pharmacol Biochem Behav 29:39-43
103. Schulteis G, Markou A, Cole M, Koob GF (1995) Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci USA 92:5880-5884
104. Schwarz-Stevens KS, Files FJ, Samson HH (1992) Effects of morphine and naloxone on ethanol- and sucrose-reinforced responding in nondeprived rats. Alcohol Clin Exp Res 16:822-832
105. Self DWL, Nester EJ (1996) Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 18:463-495
106. Self DW, McClenahan AW, Beitner-Johnson D, Terwiliger RZ, Nestler EJ (1995) Biochemical adaptations in the mesolimbic dopamine system in response to heroin self-administration. Synapse 21:312-318
107. Sellers EM, Higgins GA, Sobell MB (1992) 5-HT and alcohol abuse. Trends Pharmacol Sci 13:69-75
108. Shippenberg TS, Bals-Kubik R (1995) Involvement of the mesolimbic dopamine system in mediating the aversive effects of opioid antagonists in the rat. Behav Pharmacol 6:99-106
109. Shippenberg TS, Herz A (1988) Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. Eur J Pharmacol 151: 233-242
110. Shippenberg TS, Bals-Kubik R, Huber A, Herz A (1991) Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists. Psychopharmacology 103:209-214
111. Shippenberg TS, Bals-Kubik R, Herz A (1993) Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther 265:53-59
112. Sinclair JD (1990) Drugs to decrease alcohol drinking. Ann Med 22:357-362
113. Spanagel R (1995) Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav Brain Res 70:37-40
114. Spanagel R, Herz A, Shippenberg TS (1990a) The influence of opioid peptides on dopamine release in the nucleus accumbens: an in-vitro microdialysis study. J Neurochem 55:1734-1740
115. Spanagel R, Herz A, Shippenberg TS (1990b) Identification of the opioid receptor types mediating β-endorphin-indueed alterations in dopamine release in the nucleus accumbens. Eur J Pharmacol 190:177-184
116. Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046-2050
117. Spanagel R, Montkowski A, Allingham K, Stöhr T, Shoaib M, Holsboer F, Landgraf R (1995) Anxiety: a potential predictor of vulnerability to the initiation of ethanol self-administration in rats. Psychopharmacology 122:369-373
118. Stinus L, Cador M, Le Moal M (1992) Interactions between endogenous opioids and dopamine within the nucleus accumbens. In: Kalivas PW, Samson H (eds) The neurobiology of drug and alcohol addiction. Ann NY Acad Sci 654:254-273
119. Sweep CGJ, Wiegant VM, De Vry J, Van Ree JM (1989) β-Endorphin in brain limbic structures as neurochemical correlate of psychic dependence on drugs. Life Sci 44:1133-1140
120. Swift RM (1995) Effect of naltrexone on human alcohol consumption. J Clin Psychiatry 56 [Suppl 7]:24-29
121. Tabakoff B, Hellevuo K, Hoffmann PL (1996) Alcohol. In: Schuster CR, Kuhar MJ (eds) Pharmacological aspects of drug dependence. Handbook of experimental pharmacology, vol 118. Springer, Berlin, pp 374-460
122. Terenius L (1994) Reward and its control by dynorphin peptides. In: Jansson B, Jörnvall H, Rydberg U, Terenius L, Vallee BL (eds) Toward a molecular basis of alcohol use and abuse. Birkhäuser, Basel, pp 9-17
123. Topel H (1988) Beta-endorphin genetics in the etiology of alcoholism. Alcohol 5:159-165
124. Ulm RR, Volpicelli JR, Volpicelli LA (1995) Opiates and alcohol self-administration in animals. J Clin Psychiatry 56 [Suppl 7]:5-14
125. Unterwald EM, Tempel A, Koob GF, Zukin RS (1989) Characterization of opioid receptors in rat nucleus accumbens following mesolimbic dopaminergic lesions. Brain Res 505:111-118
126. Van Ree JM, Ramsey N (1987) The dopamine hypothesis of opiate reward challenged. Eur J Pharmacol 134:239-243
127. Van Ree JM, Smyth DG, Colpaert FC (1979) Dependence creating properties of lipotropin C-fragment (β-endorphin): evidence for its internal control of behavior. Life Sci 24:495-502
128. Van Ree JM, Kornet M, Goosen C (1994) Neuropeptides and alcohol addiction in monkeys. In: Jansson B, Jörnvall H, Rydberg U, Terenius L, Vallee BL (eds) Toward a molecular basis of alcohol use and abuse. Birkhäuser, Basel, pp 165-175
129. Volpicelli JR, Davis MA, Olgin JE (1986) Naltrexone blocks the post-shock increase of ethanol consumption. Life Sci 38: 841-847
130. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-879
131. Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP (1995) Effect of naltrexone on alcohol "high" in alcoholics. 152:613-615
132. Weiss F, Koob GF (1991) The neuropharmacology of ethanol self-administration. In: Meyer RF, Koob GF, Lewis M, Paul S (eds) Ethanol reinforcement. Birkhäuser, Boston, pp 125-162
133. Weiss F, Mitchiner M, Bloom FE, Koob GF (1990) Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected wistar rats is differentially modified by naloxone, bromocriptinc, and methysergide. Psychopharmacology 101: 178-186
134. Weiss F, Lorang MT, Bloom FE, Koob GF (1993) Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther 267:250-267
135. Widdowson PS, Holman RB (1992) Ethanol-induced increase in endogenous dopamine release may involve endogenous opiates. J Neurochem 59:157-163
136. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492
137. Wozniak KM, Pert A, Mele A, Linnoila M (1991) Focal application of alcohols elevates extracellular dopamine in rat brain: a microdialysis study. Brain Res 540:31-40
138. Yoshimoto K, McBride WJ, Lumeng L, Li T-K (1991) Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol 9:17-22